Collecting data on patients with low-grade ovarian or peritoneal tumors
Data Collection for Patients With Low Grade Ovarian Carcinoma
This study is collecting information from around 1600 women with low-grade ovarian or peritoneal tumors to help understand their disease and improve future treatments.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Sex | Female |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT00488878 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather comprehensive data on approximately 1600 female patients diagnosed with low-grade ovarian or peritoneal tumors. It focuses on collecting both prospective and retrospective information regarding disease characteristics, treatment regimens, and patient outcomes. The data will be organized in a secure repository to facilitate future research and improve understanding of these tumor types. Additionally, tumor samples will be collected to establish a tumor bank for further analysis.
Who should consider this trial
Good fit: Ideal candidates for this study are female patients diagnosed with low-grade ovarian or peritoneal tumors, including those whose disease has progressed to a higher-grade carcinoma.
Not a fit: Patients with high-grade ovarian or peritoneal tumors may not receive any benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and treatment options for patients with low-grade ovarian and peritoneal tumors.
How similar studies have performed: Other studies focusing on data collection and tumor banking have shown success in enhancing research and treatment strategies for various cancers.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients whose disease progressed to a higher-grade carcinoma since the time of original diagnosis: * Ovarian tumor of low malignant potential * Low-grade serous carcinoma of the ovary * Primary peritoneal tumor of low malignant potential * Low-grade serous carcinoma of the peritoneum * Psammocarcinoma
Where this trial is running
Houston, Texas
- M D Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: David M Gershenson — M.D. Anderson Cancer Center
- Study coordinator: Lisa Nathan
- Email: lcnathan@mdanderson.org
- Phone: 713-745-3837
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.